BioInvent International: BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma
LUND, SE / ACCESS Newswire / March 20, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class i ...
The Manila Times6d
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
Connie Britton Shares Why She Decided to Pursue Adoption as a Single Mom
Connie Britton shares why she decided to pursue adoption as a single mom. The actress adopted her son Yoby in 2011 from Ethiopia.
Korro Reports Full Year 2024 Financial Results and Provides Business Updates
Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim readout expected in the second half of 2025 —U.S. Food and ...
Seeking Alpha6d
Korro Bio gets Orphan Drug Designation from FDA for its genetic disorder treatment
With its orphan drug designation ... The company said that the dosing of first two single ascending dose cohorts in healthy adult volunteers has been completed for KRRO-110 to treat Alpha-1 ...
Morningstar6d
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
Dosing of the first two single ascending dose cohorts in healthy adult volunteers has been completed, and an interim readout is expected in the second half of 2025. The FDA's Office of Orphan ...
pharmaphorum3d
NICE and orphan drug recommendations: Should we be more worried about non-submissions?
Leela Barham uses the very latest data – running up to November 2023 – to take stock of NICE’s Single Technology Appraisal (STA) recommendations on orphan drugs versus non-orphans.
Korro Bio, Inc.: KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...
People6d
Connie Britton Shares Why She Decided to Pursue Adoption as a Single Mom
The actress adopted her son Yoby in 2011 from Ethiopia Connie Britton is sharing why she decided to pursue adoption as a single mom ... about Ethiopia's orphan population. "I always wanted ...
Connie Britton Admits Single Motherhood Was Tough. Now She's Rewriting the Narrative (Exclusive)
In Parade's exclusive cover story, the 'Zero Day' star zeroes in on her most important project to date — after all, she says, ...
Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today ...
MarketWatch6d
Korro Bio's KRRO-110 Gets FDA Orphan Drug Designation
Korro Bio disclosed that the Food and Drug Administration granted orphan drug designation to its ... Korro said dosing of the first two single ascending dose cohorts in healthy adult volunteers ...